Erratum: An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era (Blood (2014) 123:6 (837-842))

Z. Zhou, L. H. Sehn, A. W. Rademaker

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)982
Number of pages1
JournalBlood
Volume124
Issue number6
StatePublished - Aug 7 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this